Moses Alan Charles
SEC insider (Form 3/4/5 filer). CIK 0001819501. Director at Chemomab Therapeutics Ltd. (CMMB) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 14, 2025. Located in TEL AVIV.
Companies Moses Alan Charles has filed insider reports for
- Chemomab Therapeutics Ltd. (CMMB): Director
- BiomX Inc. (PHGE): Director
Moses Alan Charles
CIK: 0001819501
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
